DRPevader: Ex vivo-diagnosis and prognosis of early diabetic retinopathy
A novel ex vivo method for immediate early diagnosis and prognosis of proliferative diabetic retinopathy (DRP) is provided with DRPevader.
DRPevader is based on the analysis of expression and activity of very few genes which can simply be determined using whole blood or a blood component. Therefore, DRPevader is the diagnostic link between the alteration of leukocyte gene expression, the activity of specific serum-markers, and proliferative DRP.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 0
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Time to Leave Home? Revealed Insights into Brood Care of Cichlids
Shell-dwelling cichlids take intense care of their offspring, which they raise in abandoned snail shells. A team at the Max Planck Institute for Biological Intelligence used 3D-printed snail shells to…
Smart Fabrics: Innovative Comfortable Wearable Tech
Researchers have demonstrated new wearable technologies that both generate electricity from human movement and improve the comfort of the technology for the people wearing them. The work stems from an…
Going Steady—Study Reveals North Atlantic’s Gulf Stream Remains Robust
A study by the University of Bern and the Woods Hole Oceanographic Institution in the USA concludes that the ocean circulation in the North Atlantic, which includes the Gulf Stream,…